U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07821671) titled 'Improving TelePrEP Initiation and Retention Outcomes in the US: The MISTR+ Study' on Sept. 09.
Brief Summary: This study uses a rapid randomized controlled trial (RCT) design to examine HIV pre-exposure prophylaxis (PrEP) delivered through telehealth. This study will develop a knowledge base of small, effective changes to digital messaging and website design to improve telemedicine PrEP (telePrEP) provision for MISTR users in the United States.
Study Start Date: March 01, 2027
Study Type: INTERVENTIONAL
Condition:
Human Immunodeficiency Virus
Intervention:
BEHAVIORAL: No Marginal Cost Interventions
The exact intervention typ...